Polydipsia and polyuria with dilute urine immediately raise suspicion for Diabetes Insipidus (DI). The real challenge is distinguishing Central (Neurogenic) DI from Nephrogenic DI, because the symptoms look identical but the mechanisms, test responses, and treatments are completely different.
1. Underlying Pathophysiology
The core difference is production versus response:
- Central (Neurogenic) DI: Problem of synthesis or release. The hypothalamus or posterior pituitary fails to produce or secrete Antidiuretic Hormone (ADH / Vasopressin).
- Nephrogenic DI: Problem of renal resistance. Adequate ADH is released, but the principal cells in the collecting ducts fail to respond due to defective V2 receptors or aquaporin-2 channels.
2. Common Etiologies
Central DI Causes
- Head trauma or traumatic brain injury (TBI)
- Neurosurgery (e.g., transsphenoidal pituitary surgery)
- Pituitary tumors or craniopharyngioma
- Infiltrative diseases (sarcoidosis, histiocytosis)
- Idiopathic / autoimmune destruction of vasopressinergic neurons
Nephrogenic DI Causes
- Lithium therapy (most common drug-induced cause)
- Electrolyte imbalances: Hypercalcemia or Hypokalemia
- Congenital mutations (most commonly X-linked AVPR2 gene)
- Chronic kidney disease or tubulointerstitial disease
3. Diagnostic Differentiation: The DDAVP Challenge
Step 1: Water Deprivation Test
Water is restricted to stimulate endogenous ADH release.
– Normal person → urine concentrates
– Both types of DI → urine remains dilute (usually < 300 mOsm/kg)
Step 2: Desmopressin (DDAVP) Administration
Exogenous ADH is given to locate the defect.
| Feature | Central DI | Nephrogenic DI |
|---|---|---|
| Primary Defect | Lack of ADH production/release | Kidney resistance to ADH |
| Endogenous ADH Level | Low | Normal or High |
| Post-DDAVP Urine Osmolality | Significant increase (>50%) | Minimal or no response (<10%) |
| Clinical Mechanism | Exogenous ADH replaces the missing hormone | Kidneys ignore exogenous ADH |
4. Key Laboratory Profile (Both Types)
- Serum Sodium → Elevated (Hypernatremia)
- Serum Osmolality → High (> 295 mOsm/kg)
- Urine Specific Gravity → Inappropriately low (< 1.005)
- Urine Osmolality → Inappropriately low (< 300 mOsm/kg)
5. Treatment Comparison
Central DI
- First-line: Desmopressin (DDAVP) — oral, nasal, or IV
- Goal: Replace the missing ADH
Nephrogenic DI
- Stop offending agents (especially Lithium) if possible
- Correct electrolytes (hypercalcemia, hypokalemia)
- Pharmacologic options:
- Thiazide diuretics — mild volume depletion → ↑ proximal reabsorption
- NSAIDs (e.g., Indomethacin) — reduce prostaglandin antagonism of ADH
- Amiloride — preferred for Lithium-induced NDI (blocks ENaC lithium entry)
Clinical Takeaway
When a patient has polyuria + hypernatremia:
- Confirm DI with low urine osmolality
- Give DDAVP
- Urine concentrates significantly → Central DI (replace ADH)
- Urine stays dilute → Nephrogenic DI (treat the kidney / underlying cause)